Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7103.279 (Published 02 August 1997) Cite this as: BMJ 1997;315:279
- Gillian Hawthorne, consultant physiciana,
- S Robson, professor of fetal medicineb,
- E A Ryall, consultant obstetricianc,
- D Sen, research midwifed,
- S H Roberts, consultant physiciand,
- M P Ward Platt, consultant paediatrician on behalf of the Northern Diabetic Pregnancy Audite
- a Hartlepool General Hospital, Hartlepool TS24 9AH
- b University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
- c North Tees General Hospital, Hardwick, Stockton on Tees TS19 8PE
- d Diabetes Resource Centre, North Tyneside Hospital, North Shields, Tyne and Wear NE29 8NH
- e Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
- Correspondence to: Dr Hawthorne
- Accepted 19 May 1997
Objective: To determine whether the St Vincent declaration (1989) target of diabetic pregnancy outcome approximating non-diabetic pregnancy outcome is near to being achieved.
Design: Prospective collection of population based information on pregnancies in women with diabetes from all participating hospitals.
Setting: District general and teaching hospitals of the former Northern region.
Subjects: 111 diabetic women booking with pregnancy during 1 January to 31 December 1994.
Main outcome measures: Diabetic control, perinatal mortality rate, fetal abnormality rate.
Results: The perinatal mortality rate was 48/1000 for diabetic pregnancies compared with 8.9/1000 for the background population (odds ratio 5.38; 95% confidence interval 2.27 to 12.70) and the neonatal mortality rate was 59/1000 compared with 3.9/1000 (15.0; 6.77 to 33.10). Two late neonatal deaths were due to congenital heart defects. Six per cent of all fetal losses (6/109 cases) were due to major malformations. The congenital malformation rate was 83/1000 compared with 21.3/1000 (3.76; 2.00 to 7.06) in the background population.
Conclusion: Diabetic pregnancy remains a high risk state with perinatal mortality and fetal malformation rates much higher than in the background population.
Though diabetic women who plan their pregnancies receive prepregnancy advice, most have poor diabetic control at conception
In diabetic pregnancies the perinatal mortality rate is five times higher, the neonatal mortality rate 15 times higher, and the congenital malformation rate four times higher than in the background population
There is a substantial excess of premature births in diabetic pregnancies
The outcome of diabetic pregnancy remains poor; better uptake of preconceptional care may improve outcome
In 1989 the St Vincent declaration stated as a five year goal that the “outcome of diabetic pregnancy should approximate that of the non-diabetic pregnancy.”1 There are no prospective data from a large population base to determine whether this goal has been achieved. Within the former Northern region, data have been collected on perinatal mortality since 1982 and on fetal anomalies since 1984.2 3 4 In 1993 it was agreed to prospectively collect population based information on the outcome of all diabetic pregnancies and to compare outcome with that of the background population. This report presents the outcome data for all pregnancies in diabetic women booked in 1994.
All hospitals caring for diabetic pregnancy within the former Northern region participated. A steering group of diabetologists, obstetricians, and a neonatologist was formed and data collection from medical, obstetric, and neonatal notes agreed. Data were collected by an audit coordinator, who was notified when a woman with insulin dependent or non-insulin dependent diabetes mellitus booked at an antenatal clinic. The audit began in September 1993 and all sites were enrolled by December 1993. All diabetic pregnancies booked between 1 January and 31 December 1994 were notified. The last pregnancy notified proceeded to delivery in July 1995.
Data were analysed by spss. Odds ratios for incidences and their 95% confidence intervals were calculated by standard methods.5 Background population data for 1994 were obtained from the collaborative perinatal mortality survey2 and the regional fetal abnormality survey.3
There were 113 booked pregnancies in 111 diabetic women (two women booked with two pregnancies in the same year); 105 women were treated with insulin before pregnancy. Figure 1 shows the glycated haemoglobin concentration (haemoglobin A1c) plotted against the reference range for each hospital at booking (0-10 weeks' gestation) and in the second trimester (14-27+6 weeks). Several different assays for glycated haemoglobin were used by the hospitals (assay ranges were variable from 2.5-4.4% to 4.5-6.5%). Eight hospitals changed assay (and reference range) during the period of data collection. Seventy one of the 113 pregnancies were planned. Prepregnancy advice was given in 57 (80%) planned pregnancies. Despite this, however, measurements of diabetic control at booking in 59 women planning pregnancy showed values in only 17 (29%) cases to be within the reference range; moderate control was recorded in 29 (49%) cases and poor control in 13 (22%).
Thirty eight women went into spontaneous labour, 19 before term. The caesarean section rate was 62% (59 cases) compared with background rates of 10.4% to 17.5% among the hospitals. Twenty nine of the 113 pregnancies (26%; 95% confidence interval 17% to 34%) had an adverse fetal outcome. Table 1 shows the absolute numbers of fetuses of diabetic women and their outcomes in relation to the background population. One hundred pregnancies lasted for at least 24 weeks. Four were twin pregnancies, giving 104 fetuses. The perinatal mortality rate was 48/1000 compared with 8.9/1000 for non-diabetic births in 1994 (odds ratio 5.38; 2.27 to 12.70). The neonatal mortality rate was 59/1000 live births compared with 3.9/1000 (15.0; 6.77 to 33.10). A measure of global mortality is to account for all fetal losses from 20 weeks of gestation together with all postnatal deaths up to 1 year of age. The global loss rate was 111/1000 compared with a population average of 16/1000 (6.9; 4.0 to 11.8).
The congenital malformation rate was 9/109 fetuses (83/1000) compared with 21.3/1000 alive at 20 weeks in 1994 (3.76; 2.00 to 7.06). Confining the analysis to fetuses of over 24 weeks' gestation gave a rate of 5/104 or 48/1000 compared with a regional rate of 16.2/1000 (2.99; 1.26 to 7.05).
Thirty five per cent of babies (36/104) weighed above the 95th centile for babies born in the Northern region.6 There was no systematic relation between the relative size of the babies and either death or serious congenital malformation. There were six live births and one stillbirth at less than 32 weeks of gestation. The odds ratio for live births at less than 32 weeks from diabetic pregnancies achieving viability was 6.2 (5.13 to 24.40). There was a substantial excess of premature births among diabetic pregnancies.
We studied all pregnancies in diabetic women within a defined geographical region which was unbiased by differential referral or selective ascertainment. Global fetal and infant loss, perinatal mortality, neonatal mortality, and malformation rates were all significantly greater than those for the background population. Plainly the St Vincent declaration goal for pregnancy outcome was not being met in 1994.
The high fetal loss rate must be interpreted with caution, as the number of diabetic pregnancies remained small. However, a similar perinatal mortality rate and major malformation rate was reported a decade ago.7 Diabetic pregnancies under close scrutiny may yield a high detection rate of fetal anomaly. The major congenital malformation rate for diabetic pregnancy was similar to that in previous reports.8 9 Some authorities maintain there is no further scope for improving the outcome of diabetic pregnancy.10
Though two thirds of the pregnancies were planned by the mother, most women had not established good diabetic control before conception. Preconceptional care reduces major congenital malformations7 8 and the spontaneous abortion rate.11 It is essential that we should improve delivery of this cost effective care.12
A major difficulty was the lack of a standardised measure of diabetic control. Many different assays of glycated haemoglobin concentration are in use with different reference ranges. This is a serious problem for all audit in diabetes. For comparison we defined good diabetic control as a measure of haemoglobin A1c concentration within the assay's reference range, moderate control as a haemoglobin A1c concentration up to 8.5%, and poor control as a haemoglobin A1c concentration exceeding 8.5%.13 14
The main finding of the Northern Diabetic Pregnancy Audit in 1994 was that one in four women with pregestational diabetes had a poor pregnancy outcome. Improvements in periconceptional care are recommended, though we recognise that other, unknown factors are related to the increased fetal malformation rate.
The Northern Diabetic Pregnancy Audit thanks the following link physicians, obstetricians, and paediatricians, without whose hard work none of this information would be available. Bishop Auckland Hospital NHS Trust: Dr A McCulloch, Mr J Foulds, Dr A Cottrell; Carlisle Hospitals NHS Trust: Dr D Large, Mr W Reid, Dr J Storr; Cheviot and Wansbeck NHS Trust: Dr E Young, Mr P Franks, Dr U Wariyar; Darlington Memorial Hospital Trust: Dr E Barnes, Mr J McDonald, Dr J Thakur; Gateshead Hospital Trust: Dr J Weaver, Mr M Das, Dr J Beesley; Hartlepool and East Durham NHS Trust: Mrs C Emmerson, Dr J Jani; North Durham Acute Hospitals NHS Trust: Dr E Sanders, Dr G Terry, Mr G E Anderson, Mr B Johnson, Dr A Speight, Dr B Thalayasingham; North Tees Hospital Trust: Dr D Carr, Mr N H Hattem, Dr I Verber; North Tyneside Trust: Mr D Evans, Dr W Houlsby; Royal Victoria Infirmary and Associated Hospitals NHS Trust: Dr R Dyer, Professor R Taylor, Professor J Davidson, Miss M Simms, Dr P Kenna; South Tees Acute Hospitals NHS Trust: Dr W Kelly, Mr R S Hutchison, Dr S Sinha; South Tyneside District: Dr J Parr, Mr A Jones, Dr M Massam; Sunderland City Hospital Trust: Dr B Chazan, Mr G McNab, Dr P Carter; West Cumbria Health Care Trust: Dr C Thompson, Mr S A Bober, Dr S Richman. Special thanks are also due to all the diabetes nurse specialists and midwives who supplied information.
Funding: Northern and Yorkshire Supradistrict Purchasers Clinical Audit Group.
Conflict of interest: None.